Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • June 17, 2022, 11:05 UTC
  • 9
  • 1 comments

(70% Positive) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K)

Comment Full text

Poseida Therapeutics (PSTX)

  • Event
  • June 16, 2022, 21:30 UTC
  • 10
  • 1 comments

(99% Neutral) Poseida Therapeutics, Inc. (PSTX) Announces Regulatory Update

Comment Full text

Rhythm Pharmaceuticals Inc (RYTM)

  • Event
  • June 16, 2022, 21:11 UTC
  • 13
  • 1 comments

(99% Neutral) RHYTHM PHARMACEUTICALS, INC. (RYTM) Announces Business Combination

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • June 16, 2022, 20:38 UTC
  • 12
  • 1 comments

(80% Positive) QUANTUM-SI INCORPORATED (QSI) Announces Business Combination

Comment Full text

Codexis Inc (CDXS)

  • Event
  • June 16, 2022, 20:31 UTC
  • 12
  • 1 comments

(99% Neutral) Codexis, Inc. (CDXS) Files Form 8-K

Comment Full text

Kezar Life Sciences Inc (KZR)

  • Event
  • June 16, 2022, 20:29 UTC
  • 12
  • 1 comments

(99% Neutral) Kezar Life Sciences, Inc. (KZR) Files Form 8-K

Comment Full text

Design Therapeutics Inc (DSGN)

  • Event
  • June 16, 2022, 20:25 UTC
  • 12
  • 1 comments

(99% Neutral) Design Therapeutics, Inc. (DSGN) Announces Regulatory Update

Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • Event
  • June 16, 2022, 20:16 UTC
  • 12
  • 1 comments

(99% Neutral) VANDA PHARMACEUTICALS INC. (VNDA) Announces Regulatory Update

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • June 16, 2022, 20:15 UTC
  • 12
  • 1 comments

(99% Neutral) VERACYTE, INC. (VCYT) Announces Regulatory Update

Comment Full text

ALX Oncology Inc (ALXO)

  • Event
  • June 16, 2022, 20:14 UTC
  • 12
  • 1 comments

(99% Neutral) ALX ONCOLOGY HOLDINGS INC (ALXO) Announces Regulatory Update

Comment Full text
  • Previous
  • 180
  • 181
  • 182
  • 183
  • 184
  • Next

Search

News categories

  • Technical Exchange News(10887)
  • Event(2275)
  • SEC News(189743)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124648)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin